Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Blockchain

XRP Plunges to New Low Despite Landmark ETF Approval

Robert Sasse by Robert Sasse
November 22, 2025
in Blockchain, ETF, Ethereum & Altcoins, Trading & Momentum
0
XRP Stock
0
SHARES
80
VIEWS
Share on FacebookShare on Twitter

Investors who anticipated a major rally following the regulatory green light for XRP exchange-traded funds are facing a harsh reality. Contrary to widespread expectations, the launch of these long-awaited investment vehicles has triggered a significant sell-off, sending the cryptocurrency’s value downward. The critical question market participants are now asking is whether this represents a typical “sell the news” event or signals a more fundamental shift as long-term holders exit their positions.

Price Action Contradicts Bullish Fundamentals

The substantial price decline appears particularly puzzling given the overwhelmingly positive regulatory developments. The protracted legal battle between Ripple and the U.S. Securities and Exchange Commission has effectively concluded. Both parties dropped their appeals in August 2025, with the civil penalty finalized at $125 million, providing the market with much-needed regulatory certainty.

Under the leadership of new SEC Chair Paul Atkins, whose approach favors innovation, XRP has achieved full integration into the mainstream U.S. financial system. The digital asset now officially holds non-security status for retail sales—a regulatory position that many competing projects aspire to but have not attained.

Institutional Demand Meets Overwhelming Selling Pressure

The trading debut of the Bitwise XRP ETF on the New York Stock Exchange represented a historic achievement for the cryptocurrency sector. Institutional interest proved immediately substantial, with the product recording net inflows exceeding $100 million alongside impressive trading volume. Additional offerings, including the ETF from Canary Capital, also registered inflows, pushing total assets under management for U.S. spot XRP ETFs toward the $400 million mark.

Should investors sell immediately? Or is it worth buying XRP?

However, this institutional accumulation has collided with determined selling. Blockchain data indicates that this scenario aligns perfectly with a “sell the news” pattern. Long-term investors, some of whom have held positions since the 2018 and 2021 market cycles, appear to be utilizing the fresh liquidity provided by ETFs to realize profits.

Technical Indicators Paint Bearish Picture

Despite these fundamentally positive developments, market technicals tell a different story. Intense selling pressure has severely impacted XRP, driving its value down by more than 16% over the past week. The asset currently trades at $1.95, establishing a new 52-week low.

While the severely oversold condition, reflected in an RSI reading of 28.8, suggests the downward move may be overextended, bearish momentum currently dominates price action.

Market Outlook

The financial infrastructure supporting XRP’s long-term growth is now firmly established, marking its entry into a new era of Wall Street accessibility through regulated products. In the immediate term, however, the market is characterized by the capitulation of frustrated retail investors contrasted against the strategic accumulation by institutional players. The pivotal issue now becomes determining when the selling pressure from established holders will finally exhaust itself.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from March 25 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

XRP: Buy or sell? Read more here...

Tags: XRP
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Technology Select Sector SPDR® Fund Stock
AI & Quantum Computing

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026
Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock
Analysis

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Next Post
Palantir Stock

Palantir Shares Face Mounting Pressure as Sentiment Shifts

Asml Stock

ASML Shares Face Geopolitical Headwinds

Lynas Stock

A Compelling Case for Lynas as a Rare Earths Powerhouse

Recommended

Alphabet Stock

Alphabet Shares Surge as Antitrust Victory Sparks Market Rally

7 months ago
Invesco DB US Dollar Index Bullish Fund Stock

Geopolitical Tensions Fuel Dollar Strength and Spotlight on Invesco’s Bullish ETF

2 weeks ago
BayWa Stock

BayWa Faces Multifaceted Crisis as Restructuring Plan Unravels

3 days ago
Merit Medical Stock

Merit Medical Shares Await Key Catalysts for Momentum Shift

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

Watsco’s Dividend Hike Contrasts with Operational Headwinds

Trending

Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

by Jackson Burston
March 25, 2026
0

Despite reporting operational headway and a narrower-than-expected quarterly loss, Talphera's stock experienced significant selling pressure. The market's...

Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026
Lumen Stock

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

March 25, 2026
Microsoft Stock

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress
  • Hain Celestial Sheds Snack Division in Strategic Overhaul
  • Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com